首页> 外文期刊>Journal of the American Academy of Dermatology >Hematopoietic stem cell transplantation for primary cutaneous gamma delta T-cell lymphoma and refractory subcutaneous panniculitis-like T-cell lymphoma
【24h】

Hematopoietic stem cell transplantation for primary cutaneous gamma delta T-cell lymphoma and refractory subcutaneous panniculitis-like T-cell lymphoma

机译:造血干细胞移植治疗原发性皮肤伽玛三角洲T细胞淋巴瘤和难治性皮下脂膜炎样T细胞淋巴瘤

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The panniculitic T-cell lymphomas (TCLs) comprise 2 distinct entities, alpha beta subcutaneous panniculitis-like TCL (SPTCL) and the gamma delta cutaneous TCLs with pannicular involvement primary cutaneous gd (PCGD)-TCL. Although outcomes for most patients with SPTCL are favorable, those with PCGD-TCLs generally have an inferior outcome, and treatment strategies have not been well defined. Allogeneic hematopoietic stem cell transplantation (HSCT) has been shown to be a potentially curative strategy in aggressive TCLs and in refractory and advanced-stage mycosis fungoides.
机译:背景:胰腺T细胞淋巴瘤(TCL)包含2个不同的实体,即αβ皮下脂膜炎样TCL(SPTCL)和伴有胰腺受累的γ-δ皮肤TCL(PCGD)-TCL。尽管大多数SPTCL患者的预后良好,但PCGD-TCL患者的预后通常较差,治疗策略尚未明确。异基因造血干细胞移植(HSCT)已被证明是积极的TCL,难治性和晚期真菌病真菌中的潜在治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号